SEC Form 4 · accession 0002086163-26-000008
Penumbra Inc · PEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shruthi Narayan
Officer — President
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 7:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001321732
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 17, 2026 | A | 3,060 | $0.00 | A | 33,880 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 17, 2026, the Reporting Person was granted 3,060 restricted stock units ("RSUs") under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs (each, an "Equity Grant Tranche") will vest equally on an annual basis, beginning on August 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation and Pinehurst Merger Sub, Inc.) occurs, the RSUs will vest as follows: the first two Equity Grant Tranches (to the extent not already vested) shall vest on the Closing, and the last two Equity Grant Tranches (to the extent not already vested) shall vest on the first and second anniversaries of the Closing, respectively, subject to continued service by the Reporting Person on the applicable vesting date.
- F2A portion of these shares is subject to vesting.
- F3Includes 65 shares purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 19, 2026.